Citation Tools

Download PDFPDF

2SPD-025 Acalabrutinib + obinutuzumab versus ibrutinib + obinutuzumab as first line in chronic lymphocytic leukemia
Free

Download to a citation manager

Cite this article as:
Claramunt García R, Muñoz Cid C, Sánchez Ruiz A, et al
2SPD-025 Acalabrutinib + obinutuzumab versus ibrutinib + obinutuzumab as first line in chronic lymphocytic leukemia